BACKGROUND: Traditional metrics may inadequately represent rates of attaining optimal oncologic care. We evaluated a composite "textbook oncologic outcome" (TOO) to assess the incidence of achieving an "optimal" clinical result after colon adenocarcinoma (CA) resection. METHODS: The National Cancer Database (NCDB) was queried to identify patients undergoing colectomy for non-metastatic CA between 2010 and 2015. TOO was defined as a margin negative resection with an AJCC compliant lymph node evaluation, no prolonged length of stay (LOS) or 30-day readmission/mortality, as well as receipt of stage appropriate adjuvant chemotherapy. RESULTS: Among 170,120 patients who underwent colectomy at 1315 hospitals, 93,204 (54.8%) achieved TOO with large variations observed among facilities. While certain factors were achieved nearly universally (R0 margin, 95.6%; no 30-day mortality, 97.2%), avoidance of prolonged LOS (77.3%) and appropriate adjuvant chemotherapy (83.0%) were achieved less consistently. On multivariable analysis, Black race/ethnicity (OR 0.82, 95% CI 0.80-0.85), Medicaid insurance (OR 0.64, 0.61-0.68), and low-volume facility (< 50/year) (OR 0.83, 0.77-0.89) were associated with decreased likelihood of TOO. Achievement of TOO was associated with improved long-term survival (HR 0.45; 95% CI 0.44-0.46). CONCLUSIONS: Roughly one-half of patients undergoing resection of CA achieved an optimal clinical outcome. TOO may be a more useful quality metric to assess patient-centric composite outcomes following surgical procedures.
BACKGROUND: Traditional metrics may inadequately represent rates of attaining optimal oncologic care. We evaluated a composite "textbook oncologic outcome" (TOO) to assess the incidence of achieving an "optimal" clinical result after colon adenocarcinoma (CA) resection. METHODS: The National Cancer Database (NCDB) was queried to identify patients undergoing colectomy for non-metastatic CA between 2010 and 2015. TOO was defined as a margin negative resection with an AJCC compliant lymph node evaluation, no prolonged length of stay (LOS) or 30-day readmission/mortality, as well as receipt of stage appropriate adjuvant chemotherapy. RESULTS: Among 170,120 patients who underwent colectomy at 1315 hospitals, 93,204 (54.8%) achieved TOO with large variations observed among facilities. While certain factors were achieved nearly universally (R0 margin, 95.6%; no 30-day mortality, 97.2%), avoidance of prolonged LOS (77.3%) and appropriate adjuvant chemotherapy (83.0%) were achieved less consistently. On multivariable analysis, Black race/ethnicity (OR 0.82, 95% CI 0.80-0.85), Medicaid insurance (OR 0.64, 0.61-0.68), and low-volume facility (< 50/year) (OR 0.83, 0.77-0.89) were associated with decreased likelihood of TOO. Achievement of TOO was associated with improved long-term survival (HR 0.45; 95% CI 0.44-0.46). CONCLUSIONS: Roughly one-half of patients undergoing resection of CA achieved an optimal clinical outcome. TOO may be a more useful quality metric to assess patient-centric composite outcomes following surgical procedures.
Authors: Alex M Almoudaris; Elaine M Burns; Alex Bottle; Paul Aylin; Ara Darzi; Charles Vincent; Omar Faiz Journal: Gut Date: 2012-02-16 Impact factor: 23.059
Authors: P J Marang-van de Mheen; J Dijs-Elsinga; W Otten; M Versluijs; H J Smeets; R Vree; W J van der Made; J Kievit Journal: Med Decis Making Date: 2011 Nov-Dec Impact factor: 2.583
Authors: Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Anne Covey; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Sujata Rao; David P Ryan; Leonard Saltz; David Shibata; John M Skibber; Constantinos Sofocleous; James Thomas; Alan P Venook; Christopher Willett Journal: J Natl Compr Canc Netw Date: 2009-09 Impact factor: 11.908
Authors: C Fischer; H F Lingsma; N van Leersum; R A E M Tollenaar; M W Wouters; E W Steyerberg Journal: Eur J Surg Oncol Date: 2015-04-30 Impact factor: 4.424
Authors: Daniel Henneman; Annelotte C M van Bommel; Alexander Snijders; Heleen S Snijders; Rob A E M Tollenaar; Michel W J M Wouters; Marta Fiocco Journal: Ann Surg Date: 2014-05 Impact factor: 12.969
Authors: Justin B Dimick; Douglas O Staiger; Nicholas H Osborne; Lauren H Nicholas; John D Birkmeyer Journal: Health Serv Res Date: 2012-03-30 Impact factor: 3.402
Authors: Aslam Ejaz; Gaya Spolverato; John F Bridges; Neda Amini; Yuhree Kim; Timothy M Pawlik Journal: Ann Surg Oncol Date: 2014-06-04 Impact factor: 5.344
Authors: Justin B Dimick; Nancy J Birkmeyer; Jonathan F Finks; David A Share; Wayne J English; Arthur M Carlin; John D Birkmeyer Journal: JAMA Surg Date: 2014-01 Impact factor: 14.766
Authors: N E Kolfschoten; J Kievit; G A Gooiker; N J van Leersum; H S Snijders; E H Eddes; R A E M Tollenaar; M W J M Wouters; P J Marang-van de Mheen Journal: Eur J Surg Oncol Date: 2012-10-25 Impact factor: 4.424
Authors: Samer A Naffouje; Muhammed A Ali; Sivesh K Kamarajah; Bradley White; George I Salti; Fadi Dahdaleh Journal: J Gastrointest Surg Date: 2022-04-19 Impact factor: 3.452
Authors: Sujay Kulshrestha; Wickii T Vigneswaran; Timothy M Pawlik; Marshall S Baker; Fred A Luchette; Wissam Raad; Zaid M Abdelsattar; Richard K Freeman; Tyler Grenda; James Lubawski Journal: Semin Thorac Cardiovasc Surg Date: 2021-08-16
Authors: J Madison Hyer; Joal D Beane; Gaya Spolverato; Diamantis I Tsilimigras; Adrian Diaz; Alessandro Paro; Djhenne Dalmacy; Timothy M Pawlik Journal: J Gastrointest Surg Date: 2021-09-10 Impact factor: 3.452